PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-87.18%
Negative EBIT growth while ECL.AX is at 1214.61%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-87.18%
Negative operating income growth while ECL.AX is at 1214.61%. Joel Greenblatt would press for urgent turnaround measures.
-113.75%
Negative net income growth while ECL.AX stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-271.43%
Negative EPS growth while ECL.AX is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-271.43%
Negative diluted EPS growth while ECL.AX is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-42.73%
Share reduction while ECL.AX is at 62.54%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-42.73%
Reduced diluted shares while ECL.AX is at 62.54%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1069.09%
Negative FCF growth while ECL.AX is at 442.17%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-100.00%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-100.00%
Negative 5Y CAGR while ECL.AX stands at 6.33%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-100.00%
Negative 3Y CAGR while ECL.AX stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
Positive long-term OCF/share growth while ECL.AX is negative. John Neff would see a structural advantage in sustained cash generation.
100.00%
5Y OCF/share CAGR at 75-90% of ECL.AX's 120.43%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
100.00%
3Y OCF/share CAGR of 100.00% while ECL.AX is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
-949.37%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.